Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Articles, guides, and regulatory updates from our community.
New research suggests thymosin alpha-1 may directly protect neurons via orexin receptor signaling. Learn what this study means for stroke and neuroprotection.
By Peptide Association Research Team
New research suggests thymosin alpha-1 may protect neurons by engaging orexin receptors and suppressing necroptosis. Learn what the study found and its implications.
By Peptide Association Research Team
A 2026 review in Current Pain and Headache Reports examines regenerative peptides for chronic pain and tissue repair. Learn what the evidence shows.
By Peptide Association Research Team
A 2026 clinical review explores regenerative peptides like BPC-157, TB-4, and GHK-Cu for tissue repair and chronic pain. Here's what the evidence says.
By Peptide Association Research Team
A 2026 review examines regenerative peptides like BPC-157, TB-500, and GHK-Cu for chronic pain and tissue repair. Learn what the evidence says.
By Peptide Association Research Team
A 2026 review examines regenerative peptides for chronic pain and tissue repair. Learn what the research suggests and how to find a qualified provider.
By Peptide Association Research Team
A 2026 review examines approved and unapproved peptides for musculoskeletal injuries and athletic performance. Learn what the evidence actually shows.
By Peptide Association Research Team
New research explores how mitochondrial dysfunction drives postoperative cognitive decline and which peptide-based therapies show promise in preclinical studies.
By Peptide Association Research Team
A landmark 2025 BMJ network meta-analysis comparing 19 obesity drugs across 262 trials reveals key trade-offs between weight loss, side effects, and heart health.
By Peptide Association Research Team
New research explores how continuous spin-freeze-drying for PEGylated peptide formulations can be scaled from lab to GMP-compatible production while maintaining quality.
By Peptide Association Research Team
New research explores scalable freeze-drying for PEGylated peptide formulations. Learn what this manufacturing breakthrough may mean for peptide therapy access.
By Peptide Association Research Team
New research reveals how telehealth rules, NP authority, and compounding infrastructure create major geographic gaps in peptide-based sexual medicine access.
By Peptide Association Research Team
A 2026 study reveals significant geographic disparities in access to peptide-based sexual medicine therapies driven by state-level healthcare policies.
By Peptide Association Research Team
A 2026 NIDDK workshop study examines how real-world evidence can fill critical gaps in GLP-1 receptor agonist safety, effectiveness, and coverage decisions.
By Peptide Association Research Team
New research explores how IL-15 and Thymosin α1 may reduce immune cell aging in liver cancer. Learn what this study found and what it means for patients.
By Peptide Association Research Team
New research on GHK-Cu peptide suggests delivery route significantly affects cognitive outcomes in aged mice. Learn what the science says and what it means for you.
By Peptide Association Research Team
New research explores how GLP-1 receptor agonists affect skin biology, inflammation, wound healing, and aesthetic aging. Learn what the evidence shows.
By Peptide Association Research Team
New research on retatrutide shows promising weight loss and metabolic results. Learn what the 2026 clinical review found about this triple hormone receptor agonist.
By Peptide Association Research Team
New research suggests IL-15 combined with Thymosin α1 may reverse immune cell aging in hepatocellular carcinoma. Learn what the study found and why it matters.
By Peptide Association Research Team
New research suggests IL-15 combined with Thymosin α1 may reverse immune cell aging in liver cancer. Learn what this preclinical study found.
By Peptide Association Research Team
New research on SS-31 peptide-loaded liposomes suggests potential for targeting mitochondrial function in fat cells. Study shows promising results in animal models.
By Peptide Association Research Team
New research examines approved vs unapproved peptides for musculoskeletal injuries. Study reveals safety gaps in gray market compounds lacking oversight.
By Peptide Association Research Team
Recent veterinary research on treating dry eye disease offers insights for peptide therapy providers. Find qualified doctors and learn about emerging treatments.
By Peptide Association Research Team